Predicted protein targets (top 9)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | GRM2 | Q14416 | 3/20 | 0.46 |
| ▸ | TSHR | P16473 | 1/20 | 0.40 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.40 |
| ▸ | CYP2A6 | P11509 | 1/20 | 0.35 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.35 |
| ▸ | MGLL | Q99685 | 2/20 | 0.34 |
| ▸ | HRH3 | Q9Y5N1 | 2/20 | 0.34 |
| ▸ | TBXA2R | P21731 | 1/20 | 0.33 |
| ▸ | CYP19A1 | P11511 | 3/20 | 0.32 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL4650784 | 1.00 | GRM2 (0.46) | GRM2TSHRHSD17B10CYP2A6ALDH1A1 | |
| SCHEMBL9719633 | 0.99 | GRM2 (0.48) | GRM2TSHRHSD17B10CYP2A6ALDH1A1 | |
| SCHEMBL9362811 | 0.99 | GRM2 (0.48) | GRM2TSHRHSD17B10CYP2A6ALDH1A1 | |
| SCHEMBL5348257 | 0.99 | GRM2 (0.48) | GRM2TSHRHSD17B10CYP2A6ALDH1A1 | |
| SCHEMBL10865557 | 0.99 | GRM2 (0.48) | GRM2TSHRHSD17B10CYP2A6ALDH1A1 | |
| SCHEMBL8975343 | 0.99 | GRM2 (0.48) | GRM2TSHRHSD17B10CYP2A6ALDH1A1 | |
| SCHEMBL11290099 | 0.99 | GRM2 (0.48) | GRM2TSHRHSD17B10CYP2A6ALDH1A1 | |
| SCHEMBL9362814 | 0.99 | GRM2 (0.48) | GRM2TSHRHSD17B10CYP2A6ALDH1A1 | |
| SCHEMBL10637970 | 0.96 | TSHR (0.47) | GRM2TSHRHSD17B10ALDH1A1HRH3 | |
| SCHEMBL1934266 | 0.96 | GRM2 (0.41) | GRM2TSHRHSD17B10CYP2A6MGLL |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 21 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-4364838-A | Liquid crystal mixtures | HOFFMANN-LA ROCHE INC. (US) | 1982-12-21 | — | — | US | claimed |
| EP-2511318-B1 | METHOD FOR PRODUCING CONJUGATED POLYMER | FUJIFILM CORP (JP) | 2018-02-21 | — | — | EP | disclosed |
| US-9449732-B2 | Charge transport film, method for producing the same, and light-emitting element and photoelectric conversion element using the same | FUJIFILM CORPORATION (JP) | 2016-09-20 | — | — | US | disclosed |
| EP-2511318-A1 | METHOD FOR PRODUCING CONJUGATED POLYMER | FUJIFILM Corporation (JP) | 2012-10-17 | — | — | EP | disclosed |
| EP-2507851-A1 | CHARGE TRANSPORT FILM, METHOD FOR PRODUCING THE SAME, AND LIGHT-EMITTING ELEMENT AND PHOTOELECTRIC CONVERSION ELEMENT USING THE SAME | FUJIFILM Corporation (JP) | 2012-10-10 | — | — | EP | disclosed |
| US-20120241326-A1 | METHOD OF PREPARING CONJUGATED POLYMER | FUJIFILM CORPORATION (JP) | 2012-09-27 | — | — | US | disclosed |
| US-20120238774-A1 | CHARGE TRANSPORT FILM, METHOD FOR PRODUCING THE SAME, AND LIGHT-EMITTING ELEMENT AND PHOTOELECTRIC CONVERSION ELEMENT USING THE SAME | FUJIFILM CORPORATION (JP) | 2012-09-20 | — | — | US | disclosed |
| WO-2011068232-A1 | CHARGE TRANSPORT FILM, METHOD FOR PRODUCING THE SAME, AND LIGHT-EMITTING ELEMENT AND PHOTOELECTRIC CONVERSION ELEMENT USING THE SAME | FUJIFILM CORPORATION (JP) | 2011-06-09 | — | — | WO | disclosed |
| EP-0332392-B1 | Dioxane liquid crystal compounds | SHOWA SHELL SEKIYU (JP) | 1994-12-07 | — | — | EP | disclosed |
| EP-0318003-B1 | A liquid crystal composition for twist nematic mode | CHISSO CORP (JP) | 1993-10-20 | — | — | EP | disclosed |
| US-4923632-A | LOW THRESHOLD-VOLTAGE AND TEMPERATURE DEPENDENCY; CYCLOHEXYL-AND FLUORO-SUBSTITUTED BENZENE | CHISSO CORPORATION (JP) | 1990-05-08 | — | — | US | disclosed |
| EP-0167912-B1 | LIQUID CRYSTAL MIXTURES CONTAINING COMPOUNDS WITH A 4-ALKENYL OR 2Z-ALKENYL LATERAL CHAIN | F. HOFFMANN-LA ROCHE AG (CH) | 1990-01-03 | — | — | EP | disclosed |
| EP-0126949-B1 | FLUORINE-CONTAINING PYRIMIDINE DERIVATIVES | MERCK PATENT GmbH (DE) | 1989-09-27 | — | — | EP | disclosed |
| EP-0332392-A2 | Dioxane liquid crystal compounds | Showa Shell Sekiyu Kabushiki Kaisha (JP) | 1989-09-13 | — | — | EP | disclosed |
| EP-0318003-A2 | A liquid crystal composition for twist nematic mode | CHISSO CORPORATION (JP) | 1989-05-31 | — | — | EP | disclosed |
| US-4812258-A | LIQUID CRYSTAL DIELECTRICS | MERCK PATENT GESELLSCHAFT MIT BESCHRANKTER HAFTUNG (DE) | 1989-03-14 | — | — | US | disclosed |
| EP-0167912-A2 | Liquid crystal mixtures containing compounds with a 4-alkenyl or 2Z-alkenyl lateral chain | F. HOFFMANN-LA ROCHE AG (CH) | 1986-01-15 | — | — | EP | disclosed |
| EP-0126949-A2 | Fluorine-containing pyrimidine derivatives | MERCK PATENT GmbH (DE) | 1984-12-05 | — | — | EP | disclosed |
| US-4364838-A | Liquid crystal mixtures | HOFFMANN-LA ROCHE INC. (US) | 1982-12-21 | — | — | US | disclosed |
| EP-0064193-A1 | 4,4'-Bis-(cyclohexyl)-biphenyl derivatives that contain fluorine, dielectrics containing them, and electro-optical indicator element | MERCK PATENT GmbH (DE) | 1982-11-10 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20120238774-A1 | CHARGE TRANSPORT FILM, METHOD FOR PRODUCING THE SAME, AND LIGHT-EMITTING ELEMENT AND PHOTOELECTRIC CONVERSION ELEMENT USING THE SAME | PCTP, CDH1, PLTP | GRM2 2589/4885TSHR 4347/4885HSD17B10 3518/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.